1
Alfian, Sofa D, Worawutputtapong, Pawida, Schuiling-Veninga, Catharina C M, van der Schans, Jurjen, Bos, JH, Hak, Eelko, Denig, Petra
Veröffentlicht in: Alfian , S D , Worawutputtapong , P , Schuiling-Veninga , C C M , van der Schans , J , Bos , JH , Hak , E & Denig , P 2018 , ' Pharmacy-based predictors of non-persistence with and non-adherence to statin treatment among patients on oral diabetes medication in the Netherlands ' , Current Medical Research and Opinion , vol. 34 , no. 6 , pp. 1013-1019 . https://doi.org/10.1080/03007995.2017.1417242;
2018
Veröffentlicht in: Alfian , S D , Worawutputtapong , P , Schuiling-Veninga , C C M , van der Schans , J , Bos , JH , Hak , E & Denig , P 2018 , ' Pharmacy-based predictors of non-persistence with and non-adherence to statin treatment among patients on oral diabetes medication in the Netherlands ' , Current Medical Research and Opinion , vol. 34 , no. 6 , pp. 1013-1019 . https://doi.org/10.1080/03007995.2017.1417242;
2018
2
3
4
5
6
7
de Vries, Folgerdiena M., Denig, Petra, Visser, Sipke T., Hak, Eelko, Postma, Maarten J.
Veröffentlicht in: de Vries , F M , Denig , P , Visser , S T , Hak , E & Postma , M J 2014 , ' Cost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the Netherlands ' , Value in Health , vol. 17 , no. 2 , pp. 223-230 . https://doi.org/10.1016/j.jval.2013.12.010;
2014
Veröffentlicht in: de Vries , F M , Denig , P , Visser , S T , Hak , E & Postma , M J 2014 , ' Cost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the Netherlands ' , Value in Health , vol. 17 , no. 2 , pp. 223-230 . https://doi.org/10.1016/j.jval.2013.12.010;
2014
8
9
Stuijt, Peter J C, Heringa, Mette, van Dijk, Liset, Faber, Adrianne, Burgers, Jako S, Feenstra, Talitha L, Taxis, Katja, Denig, Petra
Veröffentlicht in: Stuijt , P J C , Heringa , M , van Dijk , L , Faber , A , Burgers , J S , Feenstra , T L , Taxis , K & Denig , P 2024 , ' Effects of a multicomponent communication training to involve older people in decisions to DEPRESCRIBE cardiometabolic medication in primary care (CO-DEPRESCRIBE) : protocol for a cluster randomized controlled trial with embedded process and economic evaluation ' , BMC primary care , vol. 25 , no. 1 , 210 . https://doi.org/10.1186/s12875-024-02465-7;
2024
Veröffentlicht in: Stuijt , P J C , Heringa , M , van Dijk , L , Faber , A , Burgers , J S , Feenstra , T L , Taxis , K & Denig , P 2024 , ' Effects of a multicomponent communication training to involve older people in decisions to DEPRESCRIBE cardiometabolic medication in primary care (CO-DEPRESCRIBE) : protocol for a cluster randomized controlled trial with embedded process and economic evaluation ' , BMC primary care , vol. 25 , no. 1 , 210 . https://doi.org/10.1186/s12875-024-02465-7;
2024
10